The emerging approach of the medication represents a significant advance in the care of the condition. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide975471.blogrenanda.com/48973730/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment